Stray Viruses in Vaccines The information on this website is not a substitute for A theory has been floating around for several years that AIDS and other diseases were created and spread by scientists, and some versions even suggest that this was done intentionally to eradicate certain segments of the population. A recent study published in the prestigious medical journal Lancet provides some evidence to support at least part of that theory. For many years, cells and blood from African green monkeys and macaques have been used for vaccine trials. Naturally, scientists want to insure that the animals are healthy, since the vaccines produced from this process will be injected into humans. So animals are first screened by visual examination and blood tests for any signs of disease. But research has now revealed that even apparently healthy animals with normal blood screens can be infected with latent viruses and retroviruses. Using sophisticated genetic analysis, investigators have found that retroviruses may have been activated in the cells of the monkeys during the preparation of polio vaccines. Passed on to people receiving those vaccines, monkey retroviruses could mutate and cause human disease. According to some sources, contaminated vaccines continue to be produced from infected monkey kidney cells to this day. Some researchers claim that vaccines carry a wide variety of viral contaminants, including herpes B, cytomegalovirus, Epstein-Barr and HIV. They blame the wide variety of unusual cancers and autoimmune disorders that are so prevalent today on these agents. Retroviruses in hepatitis B vaccine that was partly prepared with contaminated monkeys are alleged to have begun the AIDS epidemic. Why doesn't the Food & Drug Administration (FDA) step in to take contaminated vaccines off the market? Critics claim that proprietary laws and non-disclosure agreements made with the pharmaceutical industry muzzle the agency, so it can't warn scientists or health practitioners about the existence of contaminants. Based on information in: Lancet, 6 June 1998; Nexus, June-July 1998 |
Excerpted from Spectrum Magazine